immunity News and Research

RSS

New Olympus Discovery Center opens to advance human disease research

Olympus is proud to announce the opening of the Olympus Discovery Center at Texas A&M Health to support research focused on treating, alleviating and preventing human diseases.

17 Feb 2022

Smartphone-based COVID-19 detection system

In this interview, we speak to Professor Michael Mahan about his latest research which aimed to bring low-cost, state-of-the-art diagnostics to resource-limited settings.

17 Feb 2022

Study looks at COVID-19 vaccine hesitancy in France and Italy

A recent study posted to Research Square* preprint server, and under consideration at the journal Scientific Reports, aimed to learn more about how and to what extent vaccine hesitancy can alter over time at the individual level by considering parameters such as dynamic preferences, news reporting, and gender influence.

16 Feb 2022

Single dose of BNT162b2 vaccine after COVID provides 82% reduction in reinfection risk

Researchers compare the incidence rate of reinfection in convalescent and unvaccinated people to that in recovered and single-dose vaccinated people.

16 Feb 2022

Omicron breakthrough boosts neutralization titers a little more than a 3rd COVID vaccine dose

Researchers compare the neutralizing antibody titers in individuals who received two or three mRNA vaccine doses and experienced breakthrough infections.

16 Feb 2022

Study analyzes trends in overdose deaths from use of non-benzodiazepines and gabapentinoids

With an alarming rise in the number of prescriptions filled for non-benzo sleeping/z-drugs and anti-epilepsy gabapentinoids over the last two decades, researchers at Columbia University Mailman School of Public Health aimed to fill in the gap in knowledge in the proportion of overdose deaths involving those medications and learn more about their co-usage with other substances across U.S. demographics categories.

16 Feb 2022

New cholera vaccine generates long-lasting antibody responses in mice

Cholera, a diarrheal disease caused by the highly transmissible bacteria Vibrio cholerae, kills tens of thousands of people each year worldwide.

16 Feb 2022

Children with severe COVID-19 show low mucosal neutralizing activity against SARS-CoV-2

A new study examines neutralizing responses to the ancestral variant of SARS-CoV-2, as well as against later variants of concern.

16 Feb 2022

Study confirms that pets can harbor SARS-CoV-2 infection

A new study looks at how dogs and cats within households are susceptible to COVID-19 infection from humans, and whether they act as reservoir species.

16 Feb 2022

Research identifies differences between Omicron lineages BA.1 and BA.2

Researchers recently identified another Omicron lineage, called BA.2, that is more contagious than BA.1, the Omicron lineage that sparked the winter surge of coronavirus cases in January 2022.

16 Feb 2022

Impact of Omicron on COVID-19 prevalence among unvaccinated and vaccinated in Omicron-dominated countries

Scientists have recently explored the impact of the omicron variant of SARS-CoV-2 on the prevalence of COVID-19 in vaccinated and unvaccinated individuals.

16 Feb 2022

Study explores how the electrostatic charge of the SARS-CoV-2 spike protein has changed over time

In a new study, researchers examined the effect of electrostatic changes on the ability of the SARS-CoV-2 Omicron variant to escape immunity.

16 Feb 2022

COVID-19 vaccine boosters shown to confer protection against the SARS-CoV-2 Omicron variant

In a new study, researchers investigated whether a COVID-19 vaccine booster dose is effective against the SARS-CoV-2 Omicron variant.

16 Feb 2022

COVID-Somnia: the relationship between COVID-19 and insomnia

Researchers explored the links between COVID-19 and sleep disorders such as insomnia using a thorough literature review.

16 Feb 2022

Superior immune response in vaccinated after infection with Omicron compared to unvaccinated

In a recent study posted to the medRxiv* preprint server, researchers evaluated the cross-reactivity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant-triggered neutralization and fragment crystallizable (Fc) effector functions between coronavirus disease 2019 (COVID-19)-vaccinated and unvaccinated individuals in South Africa.

16 Feb 2022

The long-term consequences of SARS-CoV-2 infection in people with HIV

In a recent study posted to the medRxiv* preprint server, an interdisciplinary team of researchers from the United States (US) analyzed a cohort of patients with human immunodeficiency virus (HIV) (PWH) recovering from coronavirus disease 2019 (COVID-19) and characterized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific immune responses in these patients.

15 Feb 2022

immunity News and Research

New Olympus Discovery Center opens to advance human disease research

Smartphone-based COVID-19 detection system

Study looks at COVID-19 vaccine hesitancy in France and Italy

Single dose of BNT162b2 vaccine after COVID provides 82% reduction in reinfection risk

Omicron breakthrough boosts neutralization titers a little more than a 3rd COVID vaccine dose

Study analyzes trends in overdose deaths from use of non-benzodiazepines and gabapentinoids

New cholera vaccine generates long-lasting antibody responses in mice

Children with severe COVID-19 show low mucosal neutralizing activity against SARS-CoV-2

Study confirms that pets can harbor SARS-CoV-2 infection

Research identifies differences between Omicron lineages BA.1 and BA.2

Impact of Omicron on COVID-19 prevalence among unvaccinated and vaccinated in Omicron-dominated countries

Study explores how the electrostatic charge of the SARS-CoV-2 spike protein has changed over time

COVID-19 vaccine boosters shown to confer protection against the SARS-CoV-2 Omicron variant

COVID-Somnia: the relationship between COVID-19 and insomnia

Superior immune response in vaccinated after infection with Omicron compared to unvaccinated

The long-term consequences of SARS-CoV-2 infection in people with HIV

Research suggests SARS-CoV-2 viral accessory proteins may play significant role in viral evolution

Neutralizing antibody levels to different SARS-CoV-2 epitopes fluctuate over time

Canadian study estimates incidence rate of reinfection in healthcare workers

Post-vaccination titers of neutralizing antibodies revealed as a moderate predictor of vaccine-induced immunity

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News